| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 4 |
| 1 | CARBOPLATIN | 3 |
| 2 | PACLITAXEL | 3 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 3 |
| 4 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 2 |
| 5 | CETIRIZINE HYDROCHLORIDE | 2 |
| 6 | DOSTARLIMAB | 2 |
| 7 | FUROSEMIDE | 2 |
| 8 | INFLIXIMAB | 2 |
| 9 | POLYETHYLENE GLYCOL 3350 | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BISACODYL 5MG | 1 | 0.0011 |
| 1 | DOSTARLIMAB | 2 | 0.0008 |
| 2 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 3 | MARC GLASSMAN | 1 | 0.0003 |
| 4 | DOCUSATE SODIUM AND SENNOSIDES | 1 | 0.0002 |
| 5 | DOCUSATE CALCIUM | 1 | 0.0002 |
| 6 | DOCUSATE SODIUM SENNOSIDES | 1 | 0.0002 |
| 7 | TIGECYCLINE | 1 | 0.0002 |
| 8 | BISACODYL | 1 | 0.0001 |
| 9 | NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 3 |
| 1 | Platinum-based Drug [EPC] | 3 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 3 |
| 4 | Corticosteroid [EPC] | 2 |
| 5 | Kinase Inhibitor [EPC] | 2 |
| 6 | Loop Diuretic [EPC] | 2 |
| 7 | Osmotic Laxative [EPC] | 2 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 1 |
| 9 | Antidote [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 1 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 3 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Folate Analog [EPC] | 1 | 0.0000 |
| 5 | Vitamin A [EPC] | 1 | 0.0000 |
| 6 | Microtubule Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Nicotinic Acid [EPC] | 1 | 0.0000 |
| 8 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Antidote [EPC] | 1 | 0.0000 |